Saccharomyces boulardii and Increased Helicobacter pylori Eradication Rate

Doses used in studies

Time to effect

Median: 10 days · IQR 10 days–10 days · Range 10 days–10 days — Reported in 1 of 1 study

Safety in these studies

adverse events (overall)No significant difference
S. boulardii reduced the frequency of adverse events ( P = 0.033) in 14-day regimen, particularly treatment-associated diarrhea ( P = 0.032). However, after the adjustment to control Type I error, results lost their significance.
from: Randomised clinical trial: efficacy and safety of H. pylori eradication treatment with and
diarrheaNo significant difference
S. boulardii reduced the frequency of adverse events ( P = 0.033) in 14-day regimen, particularly treatment-associated diarrhea ( P = 0.032). However, after the adjustment to control Type I error, results lost their significance.
from: Randomised clinical trial: efficacy and safety of H. pylori eradication treatment with and

1 of 1 paper

Randomised clinical trial: efficacy and safety of H. pylori eradication treatment with and without Saccharomyces boulardii supplementation.